Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Contextual Behav Sci ; 15: 172-180, 2020 Jan.
Article in English | MEDLINE | ID: mdl-32269915

ABSTRACT

OBJECTIVE: To report the theoretical basis and design of a novel digital Acceptance and Commitment Therapy (ACT) intervention for people with chronic pain, the Pain Tracker Self Manager (PTSM), which had promising efficacy in a recent pilot trial. METHODS: Content development by a multidisciplinary panel of experts in psychiatry, clinical psychology, nursing and social work, with feedback from a group of patients with chronic pain and their providers. Materials included paper-based sketching of a story character, visual metaphors, and a series of stories designed to deliver the theory-based components of our behavioral intervention. RESULTS: This development and design process resulted in 4 digitally delivered clinical modules that combine visual and verbal cues. In addition, it generated a series of novel ACT metaphors specifically tailored to patients with chronic pain: Pain: Injury vs. Threat, Life Navigation System, The Fog of Pain, and Get Rhythm. Consistent with ACT theory and the contextual behavioral science framework, PTSM utilized: perspective-taking, values clarification, acceptance strategies, and nursing and psychological care recommendations. DISCUSSION: Reports of the design and theoretical basis of digital health interventions are highly needed to increase the rigor of their development process and more progressively advance our body of knowledge. This pilot study developed and tested a series of ACT metaphors that can be readily used by ACT clinicians working with this population. CONCLUSION: PTSM is a novel digital ACT intervention for patients with chronic pain with features directly linked to ACT processes and theory.

2.
J Pain ; 19(9): 996-1005, 2018 09.
Article in English | MEDLINE | ID: mdl-29605691

ABSTRACT

The objective of this study was to develop and pilot test a chronic pain empowerment and self-management platform, derived from acceptance and commitment therapy, in a pain specialty setting. A controlled, sequential, nonrandomized study design was used to accommodate intervention development and to test the efficacy of the PainTracker Self-Manager (PTSM) intervention (Web-based educational modules and outcome tracking combined with tailored patient coaching sessions and provider guidance). Generalized estimating equations evaluated changes over time (baseline, 3 months, 6 months) in pain self-efficacy (primary outcome), chronic pain acceptance (activity engagement and pain willingness), perceived efficacy in patient-provider interactions, pain intensity and interference, and overall satisfaction with pain treatment (secondary outcomes) between intervention (n = 48) and usual care control groups (n = 51). The full study sample (N = 99) showed greater improvements over time (significant Group × Time interactions) in pain self-efficacy and satisfaction with pain treatment. Among study completers (n = 82), greater improvement in activity engagement as well as pain intensity and interference were also observed. These preliminary findings support the efficacy of the PTSM intervention in a pain specialty setting. Further research is needed to refine and expand the PTSM intervention and to test it in a randomized trial in primary care settings. PERSPECTIVE: We developed a Web-based patient empowerment platform that combined acceptance and commitment therapy-based educational modules and tailored coaching sessions with longitudinal tracking of treatments and patient-reported outcomes, named PTSM. Pilot controlled trial results provide preliminary support for its efficacy in improving pain self-efficacy, activity engagement, pain intensity and interference, and satisfaction with pain treatment.


Subject(s)
Acceptance and Commitment Therapy/methods , Chronic Pain , Pain Management/methods , Patient Education as Topic/methods , Self-Management/methods , Adolescent , Adult , Aged , Female , Humans , Internet , Male , Middle Aged , Patient Reported Outcome Measures , Pilot Projects , Young Adult
3.
Nurse Pract ; 42(2): 20-26, 2017 02 12.
Article in English | MEDLINE | ID: mdl-28060038

ABSTRACT

Appropriate selection and dosing of medications is essential when prescribing for older adults. Opioids are commonly employed to treat pain but must be approached with caution due to potentially dangerous adverse reactions. This article provides strategies for safely prescribing opioids for pain in older adults.


Subject(s)
Analgesics, Opioid/therapeutic use , Education, Nursing, Continuing , Inappropriate Prescribing/prevention & control , Nurse Practitioners/education , Pain Management/methods , Pain/drug therapy , Adult , Aged , Aged, 80 and over , Curriculum , Female , Frail Elderly , Humans , Male , Middle Aged
4.
Nurse Pract ; 41(5): 26-37, 2016 May 19.
Article in English | MEDLINE | ID: mdl-27096559

ABSTRACT

Escalating pain is common in the final weeks of life, requiring skilled management to assist patients with a life-limiting illness. Using a cancer model, pharmacologic approaches to treat pain in the final weeks of life are reviewed.


Subject(s)
Pain Management , Terminal Care , Humans , Pain
6.
Nurse Pract ; 38(6): 28-38; quiz 38-9, 2013 Jun 10.
Article in English | MEDLINE | ID: mdl-23640011

ABSTRACT

Many cancer survivors suffer from chronic pain related to treatment. Pain management in the survivor is similar to chronic noncancer pain, with the important caveat that new or worsening pain must be promptly assessed for malignancy. This article reviews cancer survivorship, identifies common pain problems, and discusses strategies for management.


Subject(s)
Chronic Pain/nursing , Neoplasms/nursing , Primary Care Nursing/methods , Survivors , Anxiety/nursing , Chronic Pain/etiology , Chronic Pain/psychology , Female , Humans , Middle Aged , Neoplasms/complications , Neoplasms/psychology , Nursing Methodology Research , Stress, Psychological/nursing , Survivors/psychology
7.
J Pharm Sci ; 91(5): 1343-50, 2002 May.
Article in English | MEDLINE | ID: mdl-11977110

ABSTRACT

Topical lidocaine has been recently marketed as a new treatment for post-herpetic neuralgia. The aim of our study was to characterize the absorption profile of and systemic exposure to lidocaine from patch and gel formulations in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. The bioavailability of lidocaine from the patch formulation averaged 3%, and was similar after single and repeated doses. Systemic exposure to lidocaine and monoethylglycinexylidide (MEGX), the primary active metabolite of lidocaine, after application of lidocaine gel or patches was minimal in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. Considering the benefit versus risk of topical lidocaine, systemic absorption and toxicity of lidocaine seems not to be a significant risk.


Subject(s)
Anesthetics, Local/pharmacokinetics , Herpes Zoster/complications , Lidocaine/pharmacokinetics , Neuralgia/drug therapy , Acute Disease , Administration, Cutaneous , Administration, Topical , Adult , Aged , Aged, 80 and over , Anesthetics, Local/blood , Anesthetics, Local/therapeutic use , Biological Availability , Female , Gels , Humans , Injections , Lidocaine/blood , Lidocaine/therapeutic use , Male , Middle Aged , Neuralgia/etiology , Skin Absorption
SELECTION OF CITATIONS
SEARCH DETAIL
...